Rainbow Children's Medicare Limited (RAINBOW) Fair Value & Analysis
Healthcare · IN · Market cap ₹144B
Fair value as of: Jul 3, 2026
From 26 valuation models · updated today
Share price +6.3% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹1,104 – ₹1,624 · fair‑value band ₹332.20 – ₹839.28 · the ₹1,440 price screens above the ₹575.08 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Rainbow Children's Medicare Limited (RAINBOW) currently trades at ₹1,440, while our model-based Fair Value estimate is ₹575.08 — implying the stock looks roughly 60.1% overvalued today. We read business quality at 57/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Rainbow Children's Medicare Limited generated revenue of ₹17.0B at a net margin of 16.3%. Revenue grew 24.3% year over year. It earns a return on equity of 17.9%. Net debt stands at ₹8.6B. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
Rainbow Children's Medicare Limited operates a multi-specialty paediatric, obstetrics, and gynaecology hospital chain in India. The company offers medical and healthcare services to children and women. It also provides pediatric services under brand Rainbow Children's Hospital which include newborn and pediatric intensive care; pediatric multi-specialty services; and pediatric quaternary care, such as multi-organ transplantation. In addition, the company offers women care services under Birthright brand that comprise perinatal care services, such as routine and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility support, and a range of gynecology treatments, as well as operates private pediatric DNB (Diplomate of National Board) training program offering postgraduate and fellowship opportunities to train future healthcare professionals. Rainbow Children's Medicare Limited was incorporated in 1998 and is based in Hyderabad, India.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Rainbow Children's Medicare Limited reported revenue of ₹17.0B in FY2026 versus ₹9.7B in FY2022, a compound +15.0%/yr. Reported net income was ₹2.8B in FY2026, compounding +19.1%/yr from FY2022.
Is RAINBOW fairly valued? → Check now
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$95.75 | R$123.65 | +29% |
| Fresenius SE FSNUY | $11.47 | $8.55 | -25% |
| Q0F Q0F | 2.76 SGD | 1.28 SGD | -54% |
| 5225 5225 | 8.71 MYR | 4.87 MYR | -44% |
| IHHHF IHHHF | $1.71 | $1.17 | -32% |
| Rede D'Or São Luiz S.A RDOR3 | R$32.50 | R$46.04 | +42% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Rainbow Children's Medicare Limited (RAINBOW) undervalued?
What is the fair value of RAINBOW?
What is the quality score of RAINBOW?
What is the revenue of Rainbow Children's Medicare Limited (RAINBOW)?
What is the net profit margin of RAINBOW?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.